We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-13.07%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$330B
AUM Growth
-$62B
Cap. Flow
-$3.19B
Cap. Flow %
-0.97%
Top 10 Hldgs %
11.32%
Holding
4,260
New
250
Increased
2,115
Reduced
1,487
Closed
228

Top Buys

Rank Stock Value
1
HEI.A icon
HEICO Corp Class A
HEI.A
+$966M
2
VZ icon
Verizon
VZ
+$445M
3
XOM icon
ExxonMobil
XOM
+$409M
4
COR icon
Cencora
COR
+$269M
5
ZTO icon
ZTO Express
ZTO
+$266M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$341M
2
AVTR icon
Avantor
AVTR
+$318M
3
CDK
CDK Global, Inc.
CDK
+$253M
4
CRM icon
Salesforce
CRM
+$249M
5
HCA icon
HCA Healthcare
HCA
+$242M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Healthcare 13.37%
3 Financials 12.68%
4 Industrials 10.6%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALT icon
3901
Altimmune
ALT
$580M
-12,318
Closed -$75K
ALXO icon
3902
ALX Oncology
ALXO
$262M
-643,487
Closed -$10.9M
AMAT icon
3903
CALL
Applied Materials
AMAT
$398B
-11,500
Closed -$1.52M
AMZN icon
3904
CALL
Amazon
AMZN
$2.53T
-16,000
Closed -$2.61M
APYX icon
3905
Apyx Medical
APYX
$173M
-10,861
Closed -$71K
AQB icon
3906
AquaBounty Technologies
AQB
$4.68M
-780
Closed -$29K
ARDX icon
3907
Ardelyx
ARDX
$1.25B
-29,902
Closed -$32K
ARQQ icon
3908
Arqit Quantum
ARQQ
$308M
-3,425
Closed -$1.33M
ATEX icon
3909
Anterix
ATEX
$1.82B
-4,386
Closed -$255K
ATOS icon
3910
Atossa Therapeutics
ATOS
$21.8M
-2,185
Closed -$41K
AVTX icon
3911
Avalo Therapeutics
AVTX
$1.03B
-7
Closed -$14K
AXDX
3912
DELISTED
Accelerate Diagnostics
AXDX
-1,372
Closed -$19K
BAK icon
3913
Braskem
BAK
$960M
-66,014
Closed -$1.23M
BROS icon
3914
Dutch Bros
BROS
$8.98B
-232,818
Closed -$12.9M
CAMT icon
3915
Camtek
CAMT
$6.4B
-610,164
Closed -$18.6M
CARM
3916
DELISTED
Carisma Therapeutics
CARM
-3,590
Closed -$43K
CBAT icon
3917
CBAK Energy Technology Ltd
CBAT
$43.9M
-108,825
Closed -$139K
CCD
3918
Calamos Dynamic Convertible & Income Fund
CCD
$698M
-7,907
Closed -$203K
CIA icon
3919
Citizens
CIA
$246M
-16,163
Closed -$69K
CNTB
3920
Connect Biopharma Holdings
CNTB
$132M
-60,449
Closed -$183K
CRDF icon
3921
Cardiff Oncology
CRDF
$66.2M
-10,456
Closed -$26K
CRIS icon
3922
Curis
CRIS
$9.67M
-93
Closed -$88K
CRMD icon
3923
CorMedix
CRMD
$588M
-10,675
Closed -$58K
CTMX icon
3924
CytomX Therapeutics
CTMX
$714M
-23,628
Closed -$63K
CTSO icon
3925
Cytosorbents Corp
CTSO
$22M
-13,909
Closed -$44K

Similar funds

Invesco's Q2 2022 Portfolio in Review

As of Q2 2022, Invesco held 4,260 positions worth $330B, down 16% from $392B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Invesco's Q2 2022 filing shows 250 new, 2,115 increased, 1,487 reduced and 228 closed positions. Its largest new stake was Heliogen, Inc.: 258,718 shares worth $19.1M. The largest sale was Qualcomm, an estimated $341M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2022 buy was Heliogen, Inc.: 258,718 shares worth $19.1M.
  • Invesco added most to HEICO Corp Class A in Q2 2022, an estimated $966M increase.
  • Invesco's biggest Q2 2022 reduction was Qualcomm, cutting an estimated $341M.
  • Invesco fully exited Cerner Corp in Q2 2022, selling an estimated $153M.
  • Invesco's ten largest holdings make up 11% of its $330B portfolio in Q2 2022.
  • Invesco opened 250 new positions and closed 228 in Q2 2022.
  • Invesco's portfolio value fell 16% quarter-over-quarter to $330B.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.